Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

The use of recombinant tumor antigen proteins is a realistic approach for the development of generic cancer vaccines, but the potential of this type of vaccines to induce specific CD8(+) T cell responses, through in vivo cross-priming, has remained unclear. In this article, we report that repeated v...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Valmori, Danila, Souleimanian, Naira E., Tosello, Valeria, Bhardwaj, Nina, Adams, Sylvia, O'Neill, David, Pavlick, Anna, Escalon, Juliet B., Cruz, Crystal M., Angiulli, Angelica, Angiulli, Francesca, Mears, Gregory, Vogel, Susan M., Pan, Linda, Jungbluth, Achim A., Hoffmann, Eric W., Venhaus, Ralph, Ritter, Gerd, Old, Lloyd J., Ayyoub, Maha
التنسيق: Artigo
اللغة:Inglês
منشور في: National Academy of Sciences 2007
الموضوعات:
Biological Sciences
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885608/
https://ncbi.nlm.nih.gov/pubmed/17517626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0703395104
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة